Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products

Arjun Gupta; Emmanuel S. Antonarakis; Anne H. Blaes; Christopher M. Booth; Stacie B. Dusetzina

doi:10.1001/jamanetworkopen.2022.31475

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products

Arjun Gupta, Emmanuel S. Antonarakis, Anne H. Blaes, Christopher M. Booth, Stacie B. Dusetzina

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E2231475
Journal	JAMA Network Open
Volume	5
Issue number	9
DOIs	https://doi.org/10.1001/jamanetworkopen.2022.31475
State	Published - Sep 30 2022

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr Dusetzina reported receiving grants from the Commonwealth Fund and Arnold Ventures during the conduct of the study as well as grants from the Robert Wood Johnson Foundation and the Leukemia and Lymphoma Society and personal fees from West Health and the Institute for Clinical and Economic Review outside the submitted work. No other disclosures were reported.

PubMed: MeSH publication types

Journal Article

Publisher link

10.1001/jamanetworkopen.2022.31475

Find It

Find It at U of M Libraries

Cite this

@article{a997bd0942ef4ebabd6978fa8dd98cc0,

title = "Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products",

author = "Arjun Gupta and Antonarakis, {Emmanuel S.} and Blaes, {Anne H.} and Booth, {Christopher M.} and Dusetzina, {Stacie B.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Dusetzina reported receiving grants from the Commonwealth Fund and Arnold Ventures during the conduct of the study as well as grants from the Robert Wood Johnson Foundation and the Leukemia and Lymphoma Society and personal fees from West Health and the Institute for Clinical and Economic Review outside the submitted work. No other disclosures were reported.",

year = "2022",

month = sep,

day = "30",

doi = "10.1001/jamanetworkopen.2022.31475",

language = "English (US)",

volume = "5",

pages = "E2231475",

journal = "JAMA network open",

issn = "2574-3805",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products

AU - Gupta, Arjun

AU - Antonarakis, Emmanuel S.

AU - Blaes, Anne H.

AU - Booth, Christopher M.

AU - Dusetzina, Stacie B.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Dusetzina reported receiving grants from the Commonwealth Fund and Arnold Ventures during the conduct of the study as well as grants from the Robert Wood Johnson Foundation and the Leukemia and Lymphoma Society and personal fees from West Health and the Institute for Clinical and Economic Review outside the submitted work. No other disclosures were reported.

PY - 2022/9/30

Y1 - 2022/9/30

UR - http://www.scopus.com/inward/record.url?scp=85139127825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139127825&partnerID=8YFLogxK

U2 - 10.1001/jamanetworkopen.2022.31475

DO - 10.1001/jamanetworkopen.2022.31475

M3 - Article

C2 - 36178694

AN - SCOPUS:85139127825

SN - 2574-3805

VL - 5

SP - E2231475

JO - JAMA network open

JF - JAMA network open

IS - 9

ER -

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this